Search results
Results From The WOW.Com Content Network
While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.
Athersys (ATHX) gains on encouraging results from its exploratory study on the intravenous administration of MultiStem cell therapy to treat patients suffering from ARDS.
Many investors define successful investing as beating the market average over the long term. But the risk of stock...
After being closed due to the ongoing debt crisis since 27 June 2015, the stock market crashed when the exchange was reopened on 3 August. The overall index lost over 16% of its value with bank stocks losing the maximum allowed 30% on the day's trading. [8] The Athens Stock Exchange is a member of the Federation of Euro-Asian Stock Exchanges.
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
Investors need to pay close attention to Athersys (ATHX) stock based on the movements in the options market lately.
Healthcare stocks rebounded in July, but they're still underperforming the broader market year to date. The S&P 500 Health Care Select Sector ETF (), which includes pharmaceutical giants such as ...